EFFICACY STUDIES ON A CANARYPOX-RABIES RECOMBINANT VIRUS

被引：129
|
作者：
TAYLOR, J
TRIMARCHI, C
WEINBERG, R
LANGUET, B
GUILLEMIN, F
DESMETTRE, P
PAOLETTI, E
机构：
[1] VIROGENET CORP,465 JORDAN RD,RENSSELAER TECHNOL PK,TROY,NY 12180
[2] NEW YORK STATE DEPT HLTH,WADSWORTH CTR LABS & RES,ALBANY,NY 12201
[3] RHONE MERIEUX,F-69007 LYONS,FRANCE
来源：
VACCINE | 1991年 / 9卷 / 03期
关键词：
RECOMBINANT; CANARYPOX; RABIES; FOWLPOX; VACCINIA;
D O I：
10.1016/0264-410X(91)90152-V
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Recombinant avipox viruses have been developed expressing the rabies glycoprotein gene. A fowlpox-rabies recombinant has previously been shown to be protective against live rabies virus challenge in a number of non-avian species1. This report describes the development of a canarypox-rabies recombinant. A comparison is made of the protective efficacy of this recombinant with other pox-rabies recombinants.
引用
收藏
页码：190 / 193
页数：4
相关论文
共 50 条
  • [31] A highly efficient recombinant canarypox virus-based vaccine against canine distemper virus constructed using the CRISPR/Cas9 gene editing method
    Gong, Yuchen
    Chen, Tingwei
    Feng, Na
    Meng, Xianyong
    Sun, Weiyang
    Wang, Tiecheng
    Zhao, Yongkun
    Yang, Songtao
    Song, Xiaofei
    Li, Wen
    Dong, Haiman
    Wang, Hongmei
    He, Hongbin
    Wang, Jianzhong
    Zhang, Ling
    Gao, Yuwei
    Xia, Xianzhu
    VETERINARY MICROBIOLOGY, 2020, 251
  • [32] Comparative immunogenicity and efficacy studies with oral rabies virus vaccine SAD P5/88 in raccoon dogs and red foxes
    Schuster, P
    Müller, T
    Vos, A
    Selhorst, T
    Neubert, L
    Pommerening, E
    ACTA VETERINARIA HUNGARICA, 2001, 49 (03) : 285 - 290
  • [33] Live attenuated rabies virus co-infected with street rabies virus protects animals against rabies
    Wu, Xianfu
    Franka, Richard
    Henderson, Heather
    Rupprecht, Charles E.
    VACCINE, 2011, 29 (25) : 4195 - 4201
  • [34] Efficacy of the oral rabies virus vaccine strain SPBN GASGAS in foxes and raccoon dogs
    Freuling, Conrad M.
    Eggerbauer, Elisa
    Finke, Stefan
    Kaiser, Christiane
    Kaiser, Christian
    Kretzschmar, Antje
    Nolden, Tobias
    Ortmann, Steffen
    Schroeder, Charlotte
    Teifke, Jens P.
    Schuster, Peter
    Vos, Ad
    Mettenleiter, Thomas C.
    Mueller, Thomas
    VACCINE, 2019, 37 (33) : 4750 - 4757
  • [35] Efficacy and safety of a live canine adenovirus-vectored rabies virus vaccine in swine
    Liu, Ye
    Zhang, Shoufeng
    Ma, Guangpeng
    Zhang, Fei
    Hu, Rongliang
    VACCINE, 2008, 26 (42) : 5368 - 5372
  • [36] Response of IFN-γ and IL-4 in mice inoculated with rabies virus recombinant G protein
    Rojas-Anaya, Edith
    Esquivel-Guadarrama, Fernando
    Escribano-Romero, Estela
    Blazquez, Ana Belen
    Perez, Graciela Tapia
    Ruiz, Lilia Soto
    Loza-Rubio, Elizabeth
    REVISTA MEXICANA DE CIENCIAS PECUARIAS, 2015, 6 (04) : 419 - 429
  • [37] Construction of a recombinant plasmid pSH-G containing the rabies-virus glycoprotein G gene
    Carnieli Jr, P.
    Ventura, A. M.
    Durigon, E. L.
    JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES, 2007, 13 (04) : 874 - 880
  • [38] Development and evaluation of a recombinant-glycoprotein-based latex agglutination test for rabies virus antibody assessment
    Ebenezer Angel Jemima
    Seeralan Manoharan
    Kathaperumal Kumanan
    Archives of Virology, 2014, 159 : 1987 - 1993
  • [39] A recombinant vaccinia-rabies virus in the immunocompromised host: Oral innocuity, progressive parenteral infection, and therapeutics
    Hanlon, CA
    Niezgoda, M
    Shankar, V
    Niu, HS
    Koprowski, H
    Rupprecht, CE
    VACCINE, 1997, 15 (02) : 140 - 148
  • [40] Rabies virus infection: An update
    Jackson, AC
    JOURNAL OF NEUROVIROLOGY, 2003, 9 (02) : 253 - 258
12345